|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| asco@alo33 |
161972 |
Background: AA men have higher prostate cancer PC incidence and mortality than CAU men, potentially related to biologic or socioeconomic factors. A retrospective subgroup analysis suggested greate |
2.52 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161977 |
Background: Regorafenib, a multikinase inhibitor targeting VEGFR1-3, PDGFR, TIE-2, RET, c-KIT, is approved for the treatment of adults ith advanced CRC and GIST. This study assessed its safety, PK, |
2.35 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161978 |
Background: Hispanics represent approximately 17.4 percent of the US population. A recent analysis of cancer in Hispanics as performed using the National Cancer Institutes Surveillance, Epidemiology |
2.8 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161982 |
Background: The presence of ascites has been considered a relative contraindication for performing percutaneous thermal ablation of hepatic tumors due to concerns for hemorrhage. The purpose of our |
1.88 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161987 |
Background: Current methods to extract DNA from plasma are limited by the harvesting of small quantities of poor quality DNA. Circulogene Theranostics has developed a CLIA-certified proprietary meth |
2.23 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161991 |
Background: irAE occur as a result of autoimmunity triggered by ICI during cancer treatment. We hypothesize that more patients pts ill develop any grade irAE if treated ith ICI targeting immune and |
2.52 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161997 |
Background: Despite groing numbers of older people ith cancer, treatment decisions are often challenging, since evidence-based survival data according to staging and treatment progressively declines |
2.28 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
162010 |
Background: The need for a Next-Generation Sequencing NGS orkflo in a CAPCLIA accredited laboratory is rapidly increasing as the sequencing technology matures and becomes more feasible as a diagno |
2.15 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
162017 |
Background: Mesorectal excision ME is the standard surgery for loer rectal cancer. Hoever, lateral pelvic lymph node metastasis is occasionally found, and ME ith lateral lymph node dissection LLN |
2.3 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
162022 |
Background: Gallbladder cancer GBC is a rare tumor that often presents at an advanced stage and is associated ith a poor prognosis. Little is knon about the incidence patterns and factors that inf |
2.3 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
